BioSpace News Archive

Business

OncoDNA is pleased to announce collaboration in the MDLUX2 program from INC (National Cancer Institute), Molecular Diagnostics Program funded by IBBL (Integrated BioBank of Luxembourg), the Fondation Cancer and the Fondatioun Kriibskrank Kanner

Molecular diagnostic programme for better cancer treatment kicks off

November 12, 2018
·
5 min read
Genetown

TESARO Announces Achievement of ZEJULA Prostate Cancer Development Milestones by Janssen

TESARO, Inc. today announced the achievement of development milestones that trigger an $18 million payment from Janssen Biotech Inc. (Janssen).

November 12, 2018
·
4 min read
IHC MEMBER LAUNCHES FIRST DUBAI APPEAL TO HELP RESTORE SIGHT TO REGION’S BLIND

The Fred Hollows Foundation, member of International Humanitarian City, Dubai, launches its first local campaign

November 12, 2018
·
2 min read
Prime Hospital manages acute chest pain cases at its newly opened dedicated Heart Care Center

Prime Hospital has inaugurated its new state-of-the-art center specializing in acute chest pains to help address the alarming high cases of chest ailments in the

November 12, 2018
·
2 min read
OSE Immunotherapeutics Announces Publication in Nature Communications on Anti-IL-7 Receptor Antagonist (OSE-127)

Full Antagonist Mechanism of Action Demonstrated In Vivo

November 12, 2018
·
6 min read
Business

ASLAN PHARMACEUTICALS APPOINTS ROBERT E. HOFFMAN AS INDEPENDENT DIRECTOR

ASLAN Pharmaceuticals announced today the appointment of Robert E. Hoffman as an Independent Non-Executive Director. Mr. Hoffman has more than 20 years of experience in leading and managing global biotechnology companies, and working with a number of public, late-stage oncology companies.

November 12, 2018
·
4 min read
Policy

Dubai Government Workshop and American Hospital Dubai organizes awareness campaign on breast cancer risk and prevention

Move part of effort to increase awareness and educate about preventive measures

November 12, 2018
·
1 min read
Business

Ultragenyx to Host Conference Call for Third Quarter 2018 Financial Results and Corporate Update

Ultragenyx Pharmaceutical Inc. today announced that it will host a conference call on Monday, November 5, 2018 at 5pm ET to discuss third quarter 2018 financial results and provide a corporate update.

November 12, 2018
·
1 min read
Policy

Amarin Plans to Seek FDA Approval for CV Indication for Fish Oil Drug

Clinical data for a fish-oil-based drug from Amarin Corporation PLC confirmed the drug’s ability to reduce the relative risk reduction of adverse cardiovascular events by 25 percent, including a 20 percent reduction in cardiovascular death.

November 12, 2018
·
3 min read
·
Alex Keown
As Deadliest Strain Ravages Country, Four Experimental Ebola Vaccines to Be Deployed in the Congo

As an outbreak of the Ebola virus in the Democratic Republic of the Congo worsens, a team of health officials has taken four experimental vaccines to the front lines and begun to administer it to patients who may have been exposed to the deadly virus.

November 12, 2018
·
3 min read
·
Alex Keown